11 Dec 2025
Innovations in stentless coronary intervention: from DCB technologies to bioresorbable scaffolds
Anchorperson:
A. Al Nooryani
Spokesperson:
A. Baumbach
Summary
This session delves into the evolving landscape of stentless coronary interventions, focusing on the structural diversity of Drug-Coated Balloons (DCB) and the promising future of bioresorbable scaffolds (BRS). It emphasizes the role of intracoronary imaging, particularly OCT, in optimizing these therapies. Attendees gain a comprehensive understanding of paclitaxel versus limus coatings, polymer technologies, and clinical evidence supporting these innovations, alongside insights into OCT-guided optimization of contemporary scaffold platforms like Freesolve, Tyrocore, and Fantom.
Learning Objectives
- To understand the impact of structural diversity in DCB technologies
- To evaluate the current evidence and future potential of bioresorbable scaffold platforms
- To explore the role of intracoronary imaging modalities, particularly OCT, in enhancing decision-making and procedural success for both DCB therapy and BRS implantation
